Pravin Dugel - 17 Nov 2022 Form 4 Insider Report for IVERIC bio, Inc.

Role
President
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Pravin U. Dugel
Issuer symbol
N/A
Transactions as of
17 Nov 2022
Net transactions value
$0
Form type
4
Filing time
21 Nov 2022, 18:48:50 UTC
Previous filing
05 May 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise $84,994 +8,474 +7.4% $10.03 122,473 17 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Stock Option (right to buy) Options Exercise $84,994 -8,474 -100% $10.03 0 17 Nov 2022 Common Stock 8,474 $10.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on December 30, 2012 and is currently excisable for all shares underlying the option.